Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.

NCT06579105 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Placebo (placebo matching AZD5004 film-coated tablet)
DRUG: AZD5004
DRUG: Semaglutide

Sponsor

AstraZeneca